NCT06936891 Virtual Ward for Early Discharge in Patients Receiving Inpatient Care
| NCT ID | NCT06936891 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Early Discharge |
| Study Type | INTERVENTIONAL |
| Enrollment | 306 participants |
| Start Date | 2025-04-16 |
| Primary Completion | 2028-10-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 306 participants in total. It began in 2025-04-16 with a primary completion date of 2028-10-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.
Eligibility Criteria
Inclusion Criteria: * Adult patients (≥18 years old). * Currently hospitalized and eligible for early discharge according to clinical judgment. * Ability to provide written informed consent. * Access to a smartphone or tablet with internet connection. * Patient is capable of using the Digizorg app or has support from a caregiver who can assist. * Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available). * Enrollment in one of the predefined Virtual Ward care pathways Exclusion Criteria: * Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home. * Patients who are hemodynamically unstable or require oxygen therapy \>5 liters/minute at the time of discharge. * Patients unable or unwilling to comply with home monitoring procedures. * Patients with significant cognitive impairment without adequate caregiver support. * Patients with a life expectancy less than 30 days, as assessed by the treating physician. * Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol. * Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.
Contact & Investigator
Cox van de Weg, MD, PhD
PRINCIPAL INVESTIGATOR
Erasmus Medical Center
Frequently Asked Questions
Who can join the NCT06936891 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Early Discharge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06936891 currently recruiting?
Yes, NCT06936891 is actively recruiting participants. Contact the research team at m.vanherwerden@erasmusmc.nl for enrollment information.
Where is the NCT06936891 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06936891 clinical trial?
NCT06936891 is sponsored by Erasmus Medical Center. The principal investigator is Cox van de Weg, MD, PhD at Erasmus Medical Center. The trial plans to enroll 306 participants.